Investigation into the prognostic factors of early recurrence and progression in previously untreated diffuse large B-cell lymphoma and a statistical prediction model for POD12
ObjectiveThe objective of this study is to evaluate the incidence, prognostic value, and risk factors of progression of disease within 12 months (POD12) in patients with diffuse large B-cell lymphoma (DLBCL).MethodsA retrospective analysis of the clinical, pathological, and follow-up data was carrie...
Saved in:
| Main Authors: | Ke Lian, Wenyao Zhu, Zhihui Hu, Fang Su, CaiXia Xu, Hui Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-08-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1539924/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The prognostic significance of POD24 in peripheral T-cell lymphoma
by: Huimin Chen, et al.
Published: (2024-12-01) -
Impact of circulating lymphoma cells at diagnosis on outcomes in patients with newly diagnosed de novo diffuse large B-cell lymphoma
by: Sayan Mullick Chowdhury, et al.
Published: (2025-01-01) -
A Review of Results from Clinical Trials Based on Co-Variants of the R-CHOP Regimen in Untreated Patients with Diffuse Large B-cell Lymphoma
by: Vanya Slavcheva
Published: (2021-12-01) -
Modification of the existing maximum residue levels for pendimethalin in peas (with pods), beans (with pods) and leeks
by: EFSA (European Food Safety Authority), et al.
Published: (2023-03-01) -
Cost-effectiveness of polatuzumab vedotin plus chemoimmunotherapy for untreated diffuse large B-cell lymphoma in China
by: Mengya Li, et al.
Published: (2025-08-01)